The global sports drug testing market size is expected to be valued at USD 13.4 Billion in 2022 and reach USD 20.6 Billion in 2032. Implementation of stringent norms by government bodies mandating alcohol and drug testing worldwide is likely to augment growth in the upcoming decade.
As per FMI, the sports drug testing market is anticipated to exhibit steady growth at a CAGR of 17.5% in the forecast period from 2022 to 2032. Increasing regulatory approvals for drug screening services and products, as well as high consumption of alcohol would drive the demand for sports drug testing solutions.
| Report Attribute | Key Statistics |
|---|---|
| Sports Drug Testing Market Estimated Base Year Value (2021) | USD 12.8 Billion |
| Sports Drug Testing Market Expected Market Value (2022) | USD 13.4 Billion |
| Sports Drug Testing Market Anticipated Forecast Value (2032) | USD 20.6 Billion |
| Sports Drug Testing Market Projected Growth Rate (2022 to 2032) | 17.5% CAGR |
The emergence of fingerprint-based drug testing is expected to create new growth opportunities for key players in the market. These tests are user-friendly, hygienic, less time-consuming, portable, and noninvasive, and require no specific preparation for sample handling and collection.
Fingerprint-based drug testing solutions provide high effectiveness and flexibility. These are capable of analyzing small traces of sweat on fingertips to detect drug metabolites and drugs. Increasing usage of these tests in various places such as sports arenas, criminal justice, drug rehabilitation programs, and workplaces is likely to aid growth.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Increasing consumption of illicit drugs among the young population is one of the vital factors that is projected to boost the global sports drug testing market growth in future. High crime rates related to drug abuse are also set to spur the adoption of novel drug-testing devices in various parts of the globe.
As per the World Health Organization (WHO), in 2019, approximately 180 thousand deaths were directly associated with drug use disorders across the globe and about 35 million people are estimated to be living with drug use disorders at present.
These numbers are likely to surge in the next decade with the easy availability of illegal drugs, including amphetamine, heroin, cocaine, methadone, cannabis, and methamphetamines worldwide. Spurred by the aforementioned factors, the global market is expected to grow at a rapid pace.
A drug testing program can lead to the loss of otherwise qualified athletes who fail random drug tests but have not caused any trouble. Use of marijuana either recreational or medical is legal in certain states. However, it is still illegal at the federal level and this factor can complicate things for athletes coming from these states who may have been using marijuana within their legal guidelines.
Further, it can complicate things if some athletes are treated differently as they live in one of those states than others who also test positive for marijuana. There could still be complications if marijuana is consumed as a prescribed substance for the treatment of a particular disease, yet it is used as a disqualifier for sports. The above-mentioned limitations may hinder the global sports drug testing market size in the evaluation period.
North America is projected to lead in the assessment period by generating the largest sports drug testing market share. The presence of a large number of key players in the USA and Canada and strict norms mandating workplace testing are some of the crucial factors that would push growth in the regional market.
Moreover, favourable reimbursement policies and the growing use of technologically advanced drug testing solutions across North America are anticipated to aid growth. According to the National Center for Drug Abuse Statistics, in the USA, drug overdose deaths were nearing 1 million in 2000 and the federal budget for drug control was USD 35 million in 2020.
The organization further mentioned that as of 2020, about 37.309 million Americans belonging to the age group of 12 years and above were illegal drug users, whereas approximately 50.0% of people aged 12 years and above have used drugs in their lifetime illicitly in the country. The trends are estimated to continue throughout the forthcoming years, thereby pushing sales across North America.
Sales of sports drug testing products in Asia Pacific are anticipated to surge at a considerable pace on the back of the increasing prevalence of drug-related crimes and substance abuse disorders in emerging economies, including India and China. A rising number of drug testing laboratories across South Korea, Japan, and Singapore to test the presence of any illicit substance and provide accurate results is also projected to foster growth.
Besides, the availability of sophisticated equipment like spectroscopy and high-performance liquid chromatography (HPLC), as well as skilled personnel for conducting tests to get effective results is set to propel the regional market. Ongoing development of rapid point-of-care urine tests for detecting commonly abused prescription medications, including oxycodone, methadone, opiates, benzodiazepines, and buprenorphine is also likely to fuel growth.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Some of the leading companies present in the global sports drug testing market include Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Idexx Laboratories, Dragerwerk AG & Co. KGaA, Pz Cormay, Shimadzu Corporation, Lifeloc Technologies Inc., JMB Enterprises Inc., Alere, Inc., and Thermo Fisher Scientific Inc. among others.
Leading players are focusing on various organic and inorganic growth strategies such as geographical expansion, mergers and acquisitions, and new product development to generate a high share in the global market. Meanwhile, a few other key players are investing in research and development activities to come up with innovative products and increase sales.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 17.5% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Sample Type, End User, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA., Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Quest Diagnostics Incorporated; Siemens Healthcare GmbH; Idexx Laboratories; Dragerwerk AG & Co. KGaA; Pz Cormay; Shimadzu Corporation; Lifeloc Technologies Inc.; JMB Enterprises Inc.; Alere, Inc.; Thermo Fisher Scientific Inc. |
The global sports drug testing market is set to exceed USD 20.6 Billion in 2032.
North America is set to lead the sports drug testing market in the forecast period.
Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Idexx Laboratories, Dragerwerk AG & Co. KGaA, Pz Cormay, and Shimadzu Corporation are some of the renowned companies in the sports drug testing market.
| Market Valuation (2023) | USD 1.65 billion |
|---|---|
| Market Valuation (2033) | USD 2.69 billion |
| Market CAGR (2023 to 2033) | 5.3% |
| Market Value in 2021 | USD 194.3 Million |
|---|---|
| Market Value in 2032 | USD 400.4 Million |
| Market CAGR (2022 to 2032) | 7.5% |
Explore In-vitro Diagnostics Devices Insights
View Reports
Sports Drug Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
